JP2016531087A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016531087A5 JP2016531087A5 JP2016519628A JP2016519628A JP2016531087A5 JP 2016531087 A5 JP2016531087 A5 JP 2016531087A5 JP 2016519628 A JP2016519628 A JP 2016519628A JP 2016519628 A JP2016519628 A JP 2016519628A JP 2016531087 A5 JP2016531087 A5 JP 2016531087A5
- Authority
- JP
- Japan
- Prior art keywords
- glucose challenge
- glucose
- pancreatic
- cells
- natural
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 9
- 239000008103 glucose Substances 0.000 claims 9
- 210000002237 B-cell of pancreatic islet Anatomy 0.000 claims 6
- 238000000338 in vitro Methods 0.000 claims 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 2
- 230000003914 insulin secretion Effects 0.000 claims 2
- 102000051325 Glucagon Human genes 0.000 claims 1
- 108060003199 Glucagon Proteins 0.000 claims 1
- 102100028098 Homeobox protein Nkx-6.1 Human genes 0.000 claims 1
- 101000578254 Homo sapiens Homeobox protein Nkx-6.1 Proteins 0.000 claims 1
- 101000976075 Homo sapiens Insulin Proteins 0.000 claims 1
- 101000802379 Homo sapiens Zinc transporter 10 Proteins 0.000 claims 1
- 101000818846 Homo sapiens Zinc transporter 8 Proteins 0.000 claims 1
- 102000004877 Insulin Human genes 0.000 claims 1
- 102100023915 Insulin Human genes 0.000 claims 1
- 108090001061 Insulin Proteins 0.000 claims 1
- 102100041030 Pancreas/duodenum homeobox protein 1 Human genes 0.000 claims 1
- 101710183548 Pyridoxal 5'-phosphate synthase subunit PdxS Proteins 0.000 claims 1
- 102000005157 Somatostatin Human genes 0.000 claims 1
- 108010056088 Somatostatin Proteins 0.000 claims 1
- 102100021417 Zinc transporter 8 Human genes 0.000 claims 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 claims 1
- 229960004666 glucagon Drugs 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 229940125396 insulin Drugs 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 claims 1
- 229960000553 somatostatin Drugs 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020044320A JP7354026B2 (ja) | 2013-06-11 | 2020-03-13 | ＳＣ－β細胞及び組成物並びにその生成方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361833898P | 2013-06-11 | 2013-06-11 | |
| US61/833,898 | 2013-06-11 | ||
| US201461972212P | 2014-03-28 | 2014-03-28 | |
| US61/972,212 | 2014-03-28 | ||
| PCT/US2014/041992 WO2014201167A1 (en) | 2013-06-11 | 2014-06-11 | SC-β CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020044320A Division JP7354026B2 (ja) | 2013-06-11 | 2020-03-13 | ＳＣ－β細胞及び組成物並びにその生成方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016531087A JP2016531087A (ja) | 2016-10-06 |
| JP2016531087A5 true JP2016531087A5 (enExample) | 2017-07-13 |
| JP6677634B2 JP6677634B2 (ja) | 2020-04-08 |
Family
ID=52022750
Family Applications (9)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016519628A Active JP6677634B2 (ja) | 2013-06-11 | 2014-06-11 | ＳＣ−β細胞及び組成物並びにその生成方法 |
| JP2016519627A Active JP6514689B2 (ja) | 2013-06-11 | 2014-06-11 | ＳＣ−β細胞及び組成物並びにその生成方法 |
| JP2019076519A Active JP6893527B2 (ja) | 2013-06-11 | 2019-04-12 | ＳＣ−β細胞及び組成物並びにその生成方法 |
| JP2020044320A Active JP7354026B2 (ja) | 2013-06-11 | 2020-03-13 | ＳＣ－β細胞及び組成物並びにその生成方法 |
| JP2021091996A Pending JP2021121223A (ja) | 2013-06-11 | 2021-06-01 | ＳＣ−β細胞及び組成物並びにその生成方法 |
| JP2023070217A Active JP7766641B2 (ja) | 2013-06-11 | 2023-04-21 | ＳＣ－β細胞及び組成物並びにその生成方法 |
| JP2024017609A Pending JP2024054254A (ja) | 2013-06-11 | 2024-02-08 | ＳＣ－β細胞及び組成物並びにその生成方法 |
| JP2025009884A Pending JP2025063288A (ja) | 2013-06-11 | 2025-01-23 | ＳＣ－β細胞及び組成物並びにその生成方法 |
| JP2026012730A Pending JP2026082908A (ja) | 2013-06-11 | 2026-01-29 | ＳＣ－β細胞及び組成物並びにその生成方法 |
Family Applications After (8)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016519627A Active JP6514689B2 (ja) | 2013-06-11 | 2014-06-11 | ＳＣ−β細胞及び組成物並びにその生成方法 |
| JP2019076519A Active JP6893527B2 (ja) | 2013-06-11 | 2019-04-12 | ＳＣ−β細胞及び組成物並びにその生成方法 |
| JP2020044320A Active JP7354026B2 (ja) | 2013-06-11 | 2020-03-13 | ＳＣ－β細胞及び組成物並びにその生成方法 |
| JP2021091996A Pending JP2021121223A (ja) | 2013-06-11 | 2021-06-01 | ＳＣ−β細胞及び組成物並びにその生成方法 |
| JP2023070217A Active JP7766641B2 (ja) | 2013-06-11 | 2023-04-21 | ＳＣ－β細胞及び組成物並びにその生成方法 |
| JP2024017609A Pending JP2024054254A (ja) | 2013-06-11 | 2024-02-08 | ＳＣ－β細胞及び組成物並びにその生成方法 |
| JP2025009884A Pending JP2025063288A (ja) | 2013-06-11 | 2025-01-23 | ＳＣ－β細胞及び組成物並びにその生成方法 |
| JP2026012730A Pending JP2026082908A (ja) | 2013-06-11 | 2026-01-29 | ＳＣ－β細胞及び組成物並びにその生成方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (16) | US20170029778A1 (enExample) |
| EP (4) | EP3008170A4 (enExample) |
| JP (9) | JP6677634B2 (enExample) |
| KR (12) | KR102341674B1 (enExample) |
| CN (6) | CN120796168A (enExample) |
| AU (7) | AU2014278178B2 (enExample) |
| BR (2) | BR112015030972A8 (enExample) |
| CA (3) | CA3311831A1 (enExample) |
| DE (2) | DE112014002780B4 (enExample) |
| DK (1) | DK3008168T3 (enExample) |
| GB (3) | GB2557508B (enExample) |
| HK (1) | HK1257187B (enExample) |
| MX (2) | MX2015017103A (enExample) |
| PH (1) | PH12015502767A1 (enExample) |
| RU (2) | RU2016100219A (enExample) |
| SG (3) | SG11201510176VA (enExample) |
| WO (2) | WO2015002724A2 (enExample) |
Families Citing this family (107)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2473685C2 (ru) | 2007-07-31 | 2013-01-27 | Лайфскен, Инк. | Дифференцировка человеческих эмбриональных стволовых клеток |
| CN107574142B (zh) | 2007-11-27 | 2021-07-06 | 生命扫描有限公司 | 人胚胎干细胞的分化 |
| RU2705001C2 (ru) | 2011-12-22 | 2019-11-01 | Янссен Байотек, Инк. | Дифференцировка эмбриональных стволовых клеток человека в одногормональные инсулинположительные клетки |
| MX2015008578A (es) | 2012-12-31 | 2015-09-07 | Janssen Biotech Inc | Diferenciacion de celulas madre embrionarias humanas en celulas endocrinas pancreaticas mediante el uso de relugadores de hb9. |
| EP2983694B1 (en) * | 2013-04-08 | 2022-06-22 | President and Fellows of Harvard College | Compositions for rejuvenating skeletal muscle stem cells |
| AU2014278178B2 (en) | 2013-06-11 | 2021-01-21 | President And Fellows Of Harvard College | SC-beta cells and compositions and methods for generating the same |
| SG11201609473XA (en) | 2014-05-16 | 2016-12-29 | Janssen Biotech Inc | Use of small molecules to enhance mafa expression in pancreatic endocrine cells |
| ES2985135T3 (es) | 2014-12-18 | 2024-11-04 | Harvard College | Procedimientos para generar células ß derivadas de células madre y usos de las mismas |
| US10443042B2 (en) | 2014-12-18 | 2019-10-15 | President And Fellows Of Harvard College | Serum-free in vitro directed differentiation protocol for generating stem cell-derived beta cells and uses thereof |
| CN107614678B (zh) | 2014-12-18 | 2021-04-30 | 哈佛学院校长同事会 | 干细胞来源的β细胞的产生方法及其使用方法 |
| WO2016100921A1 (en) * | 2014-12-18 | 2016-06-23 | President And Fellows Of Harvard College | METHODS FOR GENERATING STEM CELL-DERIVED β CELLS AND USES THEREOF |
| WO2016100857A1 (en) * | 2014-12-19 | 2016-06-23 | Regeneron Pharmaceuticals, Inc. | Stem cells for modeling type 2 diabetes |
| US10975355B2 (en) | 2015-04-23 | 2021-04-13 | The Regents Of The University Of California | Controlled induction of human pancreatic progenitors produces functional beta-like cells |
| ES2840076T3 (es) * | 2015-04-24 | 2021-07-06 | Univ Copenhagen | Aislamiento de células progenitoras pancreáticas bona fide |
| PT3285572T (pt) * | 2015-04-24 | 2021-03-04 | Univ Copenhagen | Método para a produção de células produtoras de insulina |
| US11332716B2 (en) | 2015-07-27 | 2022-05-17 | The Regents Of The University Of California | Methods and compositions for producing pancreatic beta cells |
| US11499140B2 (en) * | 2015-10-29 | 2022-11-15 | Juntendo Educational Foundation | Method for producing pancreatic endocrine cells, and transdifferentiation agent |
| US11116777B2 (en) | 2015-11-10 | 2021-09-14 | City Of Hope | Conditioning regimens and methods for inducing mixed chimerism |
| WO2017116569A1 (en) * | 2015-12-31 | 2017-07-06 | City Of Hope | Methods for treating diabetes |
| IL293766B2 (en) | 2016-01-06 | 2023-08-01 | Harvard College | Treatment with gdf11 prevents weight gain, improves glucose loading and reduces hepatosteatosis |
| GB2562406B (en) | 2016-01-12 | 2020-09-02 | Cedars Sinai Medical Center | A method of non destructive monitoring of biological processes in microfluidic tissue culture systems |
| AU2017213795A1 (en) | 2016-02-01 | 2018-08-16 | Cedars-Sinai Medical Center | Systems and methods for growth of intestinal cells in microfluidic devices |
| EP3420073B1 (en) * | 2016-02-24 | 2023-11-08 | Novo Nordisk A/S | Generation of functional beta cells from human pluripotent stem cell-derived endocrine progenitors |
| US20190060371A1 (en) * | 2016-03-02 | 2019-02-28 | Frequency Therapeutics, Inc. | Methods for controlled proliferation of vestibular stem cells / generating inner ear hair cells using wnt and tgfbeta-inhibition |
| US10201540B2 (en) | 2016-03-02 | 2019-02-12 | Frequency Therapeutics, Inc. | Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using GSK3 inhibitors: I |
| US10213511B2 (en) | 2016-03-02 | 2019-02-26 | Frequency Therapeutics, Inc. | Thermoreversible compositions for administration of therapeutic agents |
| MA45329A (fr) | 2016-04-08 | 2019-02-13 | Univ California | Production de cellules bêta matures pleinement fonctionnelles à partir de progénitrices pancréatiques humaines |
| WO2017214465A1 (en) * | 2016-06-09 | 2017-12-14 | Georgetown University | Process for continuous cell culture of islet cells |
| CA3027879A1 (en) * | 2016-06-21 | 2017-12-28 | Janssen Biotech, Inc. | Generation of human pluripotent stem cell derived functional beta cells showing a glucose-dependent mitochondrial respiration and two-phase insulin secretion response |
| AU2017363142B2 (en) | 2016-11-16 | 2024-05-30 | Allele Biotechnology & Pharmaceuticals, Inc. | Induction of hepatocytes by stem cell differentiation with RNA |
| IL266478B2 (en) | 2016-11-16 | 2025-02-01 | Allele Biotechnology & Pharmaceuticals Inc | Induction of pancreatic beta cells through stem cell differentiation with RNA |
| US11913022B2 (en) | 2017-01-25 | 2024-02-27 | Cedars-Sinai Medical Center | In vitro induction of mammary-like differentiation from human pluripotent stem cells |
| KR101745297B1 (ko) | 2017-02-02 | 2017-06-09 | 경북대학교 산학협력단 | 비만 진단용 조성물 및 이의 용도 |
| US11767513B2 (en) | 2017-03-14 | 2023-09-26 | Cedars-Sinai Medical Center | Neuromuscular junction |
| WO2018176001A2 (en) | 2017-03-24 | 2018-09-27 | Cedars-Sinai Medical Center | Methods and compositions for production of fallopian tube epithelium |
| US10767164B2 (en) | 2017-03-30 | 2020-09-08 | The Research Foundation For The State University Of New York | Microenvironments for self-assembly of islet organoids from stem cells differentiation |
| IL313825B2 (en) | 2017-06-14 | 2025-07-01 | Vertex Pharma | Devices and methods for administering medications |
| US20210355448A1 (en) * | 2017-06-26 | 2021-11-18 | City Of Hope | Methods of islet cell culture |
| US10391156B2 (en) | 2017-07-12 | 2019-08-27 | Viacyte, Inc. | University donor cells and related methods |
| JP2020527956A (ja) * | 2017-07-21 | 2020-09-17 | センマ・セラピューティクス・インコーポレーテッド | 幹細胞由来の膵臓ベータ細胞の再凝集 |
| CA2983845C (en) | 2017-10-26 | 2024-01-30 | University Of Copenhagen | Generation of glucose-responsive beta cells |
| WO2019099725A1 (en) | 2017-11-15 | 2019-05-23 | Semma Therapeutics, Inc. | Islet cell manufacturing compositions and methods of use |
| WO2019169351A1 (en) * | 2018-03-02 | 2019-09-06 | Semma Therapeutics, Inc. | Methods of enhancing stem cell differentiation into beta cells |
| US12161676B2 (en) | 2018-03-23 | 2024-12-10 | Cedars-Sinai Medical Center | Methods of use of islet cells |
| US11981918B2 (en) | 2018-04-06 | 2024-05-14 | Cedars-Sinai Medical Center | Differentiation technique to generate dopaminergic neurons from induced pluripotent stem cells |
| WO2019195798A1 (en) | 2018-04-06 | 2019-10-10 | Cedars-Sinai Medical Center | Human pluripotent stem cell derived neurodegenerative disease models on a microfluidic chip |
| JP7543143B2 (ja) | 2018-04-30 | 2024-09-02 | シーダーズ－サイナイ メディカル センター | 早期発症型孤発性パーキンソン病の分子シグネチャの診断及び薬物スクリーニング |
| JP2021522819A (ja) | 2018-05-07 | 2021-09-02 | プレジデント アンド フェローズ オブ ハーバード カレッジ | インビトロベータ細胞分化に関連する細胞集団および遺伝子発現 |
| WO2019217875A1 (en) | 2018-05-11 | 2019-11-14 | Cornell University | Method of differentiation of human pluripotent stem cells to monohormonal cells |
| EP3833365A4 (en) | 2018-08-10 | 2022-05-11 | Vertex Pharmaceuticals Incorporated | Stem cell derived islet differentiation |
| WO2020037323A1 (en) | 2018-08-17 | 2020-02-20 | Frequency Therapeutics, Inc. | Compositions and methods for generating hair cells by upregulating jag-1 |
| WO2020037326A1 (en) | 2018-08-17 | 2020-02-20 | Frequency Therapeutics, Inc. | Compositions and methods for generating hair cells by downregulating foxo |
| AU2018439389A1 (en) * | 2018-08-30 | 2021-02-18 | Novo Nordisk A/S | Generation of functional beta cells from human pluripotent stem cell-derived endocrine progenitors |
| US12378572B2 (en) | 2018-09-07 | 2025-08-05 | Crispr Therapeutics Ag | Universal donor cells |
| WO2020061591A1 (en) | 2018-09-21 | 2020-03-26 | President And Fellows Of Harvard College | Methods and compositions for treating diabetes, and methods for enriching mrna coding for secreted proteins |
| CN113166219A (zh) * | 2018-09-28 | 2021-07-23 | 纪念斯隆-凯特琳癌症中心 | 干细胞衍生的人小神经胶质细胞、制备方法及使用方法 |
| EP3868870B1 (en) * | 2018-10-15 | 2025-12-03 | Evia Life Sciences Inc. | Method for producing stem/precursor cells, by using low molecular weight compound, from cells derived from endodermal tissue or organ |
| KR102115960B1 (ko) * | 2018-11-28 | 2020-05-27 | 송미연 | 인간 중간엽 줄기세포를 갑상선 호르몬 분비세포로 분화 방법 |
| US20220175848A1 (en) | 2019-04-01 | 2022-06-09 | The Broad Institute, Inc. | Methods and compositions for cell therapy |
| EP3953451A1 (en) * | 2019-04-08 | 2022-02-16 | Novo Nordisk A/S | Generation of pancreatic endoderm from stem cell derived definitive endoderm |
| EP3972614A4 (en) | 2019-05-21 | 2023-08-23 | President and Fellows of Harvard College | ENDOCRINE DIFFERENTIATION INDUCTION MOLECULE |
| KR102167257B1 (ko) * | 2019-05-28 | 2020-10-19 | 부산대학교 산학협력단 | 토마티딘 처리를 통한 줄기세포의 성숙화된 심근세포로의 분화유도 촉진 방법 |
| EP3975926A1 (en) | 2019-05-31 | 2022-04-06 | W.L. Gore & Associates, Inc. | A biocompatible membrane composite |
| US12310830B2 (en) | 2019-05-31 | 2025-05-27 | W. L. Gore & Associates, Inc. | Biocompatible membrane composite |
| AU2020282355B2 (en) | 2019-05-31 | 2023-11-02 | Viacyte, Inc. | A biocompatible membrane composite |
| CA3257300A1 (en) | 2019-05-31 | 2025-06-12 | W. L. Gore & Associates, Inc. | Cell encapsulation devices with controlled oxygen diffusion distances |
| WO2020247954A1 (en) * | 2019-06-06 | 2020-12-10 | President And Fellows Of Harvard College | Compositions and methods for maturing stem cell-derived beta cells |
| WO2020264072A1 (en) | 2019-06-25 | 2020-12-30 | Semma Therapeutics, Inc. | Enhanced differentiation of beta cells |
| WO2021030424A1 (en) * | 2019-08-13 | 2021-02-18 | Semma Therapeutics, Inc. | Pancreatic differentiation |
| US10740609B1 (en) | 2019-08-30 | 2020-08-11 | Numerica Corporation | System and method for space object detection in daytime sky images |
| US11104918B2 (en) | 2019-09-05 | 2021-08-31 | Crispr Therapeutics Ag | Universal donor cells |
| US11116798B2 (en) | 2019-09-05 | 2021-09-14 | Crispr Therapeutics Ag | Universal donor cells |
| WO2021072390A1 (en) * | 2019-10-10 | 2021-04-15 | The Regents Of The University Of Colorado, A Body Corporate | Use of entpd3 for identification, isolation, and enhancing mature stem cell derived insulin-producing cells |
| US20230014430A1 (en) * | 2019-11-20 | 2023-01-19 | Washington University | Methods and Compositions for Generating Functionally Mature Beta Cells and Uses Thereof |
| JP7842690B2 (ja) | 2020-02-19 | 2026-04-08 | ナミ セラピューティクス， インコーポレイテッド | がんの処置において有用なＴＦＧβアンタゴニストプロドラッグを含有する製剤化および／または共製剤化リポソーム組成物ならびにその方法 |
| CN111269875B (zh) * | 2020-03-24 | 2022-04-08 | 山东兴瑞生物科技有限公司 | 一种利用自体免疫细胞定向分化为胰岛细胞的方法 |
| WO2021212044A1 (en) * | 2020-04-16 | 2021-10-21 | Washington University | Methods and compositions for improving sc-beta cells or enhancing their utility |
| US12473537B2 (en) | 2020-06-16 | 2025-11-18 | The Broad Institute, Inc. | Three-dimensional cell culture, devices, and use thereof |
| US20240271100A1 (en) * | 2020-07-31 | 2024-08-15 | Vertex Pharmaceuticals Incorporated | In vitro differentiation of pancreatic endocrine cells |
| JP7705448B2 (ja) | 2020-07-31 | 2025-07-09 | バーテックス ファーマシューティカルズ インコーポレイテッド | 膵内分泌細胞の分化 |
| US11566230B2 (en) | 2020-12-31 | 2023-01-31 | Crispr Therapeutics Ag | Universal donor cells |
| CN112980771B (zh) * | 2021-03-05 | 2023-12-19 | 贝康医学科技有限公司 | 一种制备胰腺beta细胞的方法及其应用 |
| CN113046299B (zh) * | 2021-03-19 | 2024-06-28 | 上海爱萨尔生物科技有限公司 | 一种诱导多能干细胞定向分化制备胰岛β细胞的添加剂 |
| CN112980774B (zh) * | 2021-03-19 | 2022-04-01 | 上海爱萨尔生物科技有限公司 | 一种诱导多能干细胞定向分化制备胰岛β细胞的培养方法 |
| CN112961823B (zh) * | 2021-03-19 | 2024-01-23 | 上海爱萨尔生物科技有限公司 | 一种诱导多能干细胞定向分化制备胰岛β细胞的培养液 |
| CN113234664B (zh) * | 2021-05-11 | 2024-05-10 | 澳门大学 | 一种胰腺祖细胞的制备方法及其应用 |
| US20220403340A1 (en) * | 2021-06-11 | 2022-12-22 | Washington University | Media for cryopreserved cells and methods of making and using same |
| WO2023278382A1 (en) | 2021-06-29 | 2023-01-05 | Staffan Holmin | Endoluminal delivery cannula |
| JP2024531805A (ja) | 2021-09-21 | 2024-08-29 | 学校法人沖縄科学技術大学院大学学園 | ヒト脳オルガノイドを使用した、シヌクレイン病に対する薬物試験のプラットフォーム |
| JP2024540987A (ja) | 2021-10-21 | 2024-11-06 | バーテックス ファーマシューティカルズ インコーポレイテッド | 低免疫細胞 |
| WO2023072170A1 (en) * | 2021-10-28 | 2023-05-04 | Sunshine Lake Pharma Co., Ltd. | A METHOD FOR PROMOTING THE DIFFERENTIATION OF STEM CELLS INTO FUNCTIONALLY MATURE ISLET β CELLS AND USE THEREOF |
| JP2024542041A (ja) | 2021-11-01 | 2024-11-13 | バーテックス ファーマシューティカルズ インコーポレイテッド | 幹細胞由来の膵臓島分化 |
| CN118355109A (zh) * | 2021-11-30 | 2024-07-16 | 杭州瑞普晨创科技有限公司 | 从多能干细胞生成功能性胰岛的方法 |
| EP4473088A4 (en) * | 2022-02-01 | 2026-01-14 | Vertex Pharma | CELL THERAPY FOR DIABETES |
| US12435312B2 (en) | 2022-02-28 | 2025-10-07 | Brown University | Quantifying cell-derived changes in collagen synthesis, alignment, and mechanics in a 3D connective tissue model |
| US20230330264A1 (en) | 2022-04-15 | 2023-10-19 | Smartcella Solutions Ab | COMPOSITIONS AND METHODS FOR EXOSOME-MEDIATED DELIVERY OF mRNA AGENTS |
| US20250367240A1 (en) * | 2022-06-03 | 2025-12-04 | Cornell University | Derivation of glucose-responsive insulin-secreting cells and organoids from human stomach cells and their use to treat diabetes |
| CN120187851A (zh) * | 2022-10-28 | 2025-06-20 | 科罗拉多大学董事会法人 | 用于加速从多能干细胞产生胸腺细胞的组合物和方法 |
| WO2024151541A1 (en) * | 2023-01-09 | 2024-07-18 | Sana Biotechnology, Inc. | Type-1 diabetes autoimmune mouse |
| US20260218132A1 (en) * | 2023-01-11 | 2026-07-30 | Mayo Foundation For Medical Education And Research | Methods and materials for generating stem cell-derived endocrine cell types |
| WO2024173283A1 (en) | 2023-02-14 | 2024-08-22 | Vertex Pharmaceuticals Incorporated | Macroencapsulation devices including immunomodulatory compounds |
| WO2024243236A2 (en) | 2023-05-22 | 2024-11-28 | Sana Biotechnology, Inc. | Methods of delivery of islet cells and related methods |
| IL325954A (en) * | 2023-07-28 | 2026-03-01 | Vertex Pharma | Cell therapy for diabetes |
| CN117672411B (zh) * | 2023-12-05 | 2024-05-14 | 首都医科大学附属北京世纪坛医院 | 一种中药成分的Hormesis效应研究方法及中药成分小檗碱的应用 |
| WO2025168061A1 (en) * | 2024-02-09 | 2025-08-14 | Endocell Therapeutics Inc | Methods for preparing endoderm stem cells and islets derived therefrom |
| WO2025235400A1 (en) * | 2024-05-06 | 2025-11-13 | Vertex Pharmaceuticals Incorporated | Novel islet potency assay |
| CN121109289A (zh) * | 2025-08-31 | 2025-12-12 | 瑞吉维思生物科技(上海)有限公司 | 高效维持胰岛β细胞身份的胰岛类器官及其制法和应用 |
Family Cites Families (170)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US130A (en) | 1837-02-16 | Improvement in metallic solutions for the preservation of timber | ||
| US6774A (en) | 1849-10-09 | Improved jointed center-board | ||
| US3270960A (en) | 1964-09-11 | 1966-09-06 | Sperry Rand Corp | Fluid sensor |
| DE1570610C3 (de) | 1965-10-01 | 1974-08-01 | Bayer Ag, 5090 Leverkusen | Verfahren zur Herstellung von Poly-N-oxyden |
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US4391909A (en) | 1979-03-28 | 1983-07-05 | Damon Corporation | Microcapsules containing viable tissue cells |
| US4378016A (en) | 1981-07-15 | 1983-03-29 | Biotek, Inc. | Artificial endocrine gland containing hormone-producing cells |
| US5425764A (en) | 1992-07-30 | 1995-06-20 | The University Of Toledo | Bioartificial pancreas |
| US6469017B1 (en) | 1998-01-16 | 2002-10-22 | Cell Therapeutics, Inc. | Method of inhibiting interleukin-12 signaling |
| US7018419B2 (en) | 1994-05-20 | 2006-03-28 | Spielberg Theodore E | Microporous encapsulated endocrine cell disks, biconcave disks and multidimpled chambers for hormonal replacement |
| US5843780A (en) | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
| EP0822834A4 (en) * | 1995-04-07 | 2002-09-18 | Einstein Coll Med | RECOMBINANT (BETA) CELL AND ITS USE |
| US6187991B1 (en) | 1995-05-23 | 2001-02-13 | Pfizer Inc | Transgenic animal models for type II diabetes mellitus |
| JPH11508477A (ja) | 1996-02-23 | 1999-07-27 | サーシ・バイオメディカル・インコーポレーテッド | 新規の人工膵臓 |
| US5994619A (en) | 1996-04-01 | 1999-11-30 | University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus | Production of chimeric bovine or porcine animals using cultured inner cell mass cells |
| EA199900355A1 (ru) | 1996-10-01 | 2000-08-28 | Джерон Корпорейшн | Теломераза обратная тринскриптаза |
| JP2001508302A (ja) | 1997-01-10 | 2001-06-26 | ライフ テクノロジーズ，インコーポレイテッド | 胚性幹細胞血清置換 |
| US5945577A (en) | 1997-01-10 | 1999-08-31 | University Of Massachusetts As Represented By Its Amherst Campus | Cloning using donor nuclei from proliferating somatic cells |
| US6090622A (en) | 1997-03-31 | 2000-07-18 | The Johns Hopkins School Of Medicine | Human embryonic pluripotent germ cells |
| WO1999020740A2 (en) | 1997-10-23 | 1999-04-29 | Geron Corporation | Methods and materials for the growth of primate-derived primordial stem cells |
| WO2001051611A1 (en) | 2000-01-14 | 2001-07-19 | Bresagen Limited | Cell production |
| US6667176B1 (en) | 2000-01-11 | 2003-12-23 | Geron Corporation | cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells |
| US7410798B2 (en) | 2001-01-10 | 2008-08-12 | Geron Corporation | Culture system for rapid expansion of human embryonic stem cells |
| GB0005251D0 (en) | 2000-03-03 | 2000-04-26 | Merck Sharp & Dohme | Therapeutic compounds |
| US6436704B1 (en) | 2000-04-10 | 2002-08-20 | Raven Biotechnologies, Inc. | Human pancreatic epithelial progenitor cells and methods of isolation and use thereof |
| EP1287116A2 (en) | 2000-05-17 | 2003-03-05 | Geron Corporation | Neural progenitor cell populations |
| US7094874B2 (en) | 2000-05-26 | 2006-08-22 | Bristol-Myers Squibb Co. | Soluble CTLA4 mutant molecules |
| US6906810B2 (en) | 2000-07-13 | 2005-06-14 | Morgan Guaranty Trust Company | Method and system for allowing an on-line user to selectively customize a document for printing in a single batch process |
| US7163918B2 (en) | 2000-08-22 | 2007-01-16 | New River Pharmaceuticals Inc. | Iodothyronine compositions |
| ATE360063T1 (de) | 2000-10-12 | 2007-05-15 | Agency Science Tech & Res | Nicht störendes, dreidimensionales system für die kultivierung und ernte verankerungsabhängiger zellen |
| ES2623711T3 (es) | 2000-10-13 | 2017-07-12 | Curis, Inc. | Antagonistas de hedgehog, procedimientos y usos relacionados con los mismos |
| US6576464B2 (en) | 2000-11-27 | 2003-06-10 | Geron Corporation | Methods for providing differentiated stem cells |
| CA2435826A1 (en) | 2001-01-24 | 2002-08-01 | The Government Of The United States Of America | Differentiation of stem cells to pancreatic endocrine cells |
| WO2002092756A2 (en) | 2001-05-15 | 2002-11-21 | Rappaport Family Institute For Research In The Medical Sciences | Insulin producing cells derived from human embryonic stem cells |
| US7432104B2 (en) | 2001-08-06 | 2008-10-07 | Bresgen Inc. | Methods for the culture of human embryonic stem cells on human feeder cells |
| US20030054331A1 (en) | 2001-09-14 | 2003-03-20 | Stemsource, Inc. | Preservation of non embryonic cells from non hematopoietic tissues |
| US20050053588A1 (en) | 2001-10-18 | 2005-03-10 | Li Yin | Conversion of liver stem and progenitor cells to pancreatic functional cells |
| US20030077256A1 (en) | 2001-10-19 | 2003-04-24 | Paul Czernichow | Pancreas regeneration using embryonic pancreatic cells |
| US7157278B2 (en) | 2001-12-04 | 2007-01-02 | Organogenesis, Inc. | Cultured cells from pancreatic islets |
| CN1630716A (zh) | 2001-12-07 | 2005-06-22 | 杰龙公司 | 人胚胎干细胞衍生的造血细胞 |
| CA2469370C (en) | 2001-12-07 | 2014-07-08 | Macropore Biosurgery, Inc. | Adipose-derived cell processing unit |
| GB2399823B (en) | 2001-12-07 | 2006-02-15 | Geron Corp | Islet cells from primate pluripotent stem cells |
| US20060003446A1 (en) | 2002-05-17 | 2006-01-05 | Gordon Keller | Mesoderm and definitive endoderm cell populations |
| WO2003102171A1 (en) | 2002-05-28 | 2003-12-11 | Becton, Dickinson And Company | Expansion and transdifferentiation of human acinar cells |
| BR0311362A (pt) * | 2002-05-28 | 2006-10-31 | Novocell Inc | métodos, composições e fatores de crescimento e de diferenciação para produzir células produtoras de insulina |
| AU2003302702B2 (en) | 2002-12-05 | 2008-08-07 | Technion Research & Development Foundation Ltd. | Cultured human pancreatic islets, and uses thereof |
| AU2003300522A1 (en) | 2002-12-27 | 2004-07-22 | Bayer Healthcare Ag | 4-phenyl-pyrimido (4,5-b) indole derivatives |
| US7172682B2 (en) | 2003-01-24 | 2007-02-06 | Rensselaer Polytechnic Institute | Enzyme immobilization for electroosmotic flow |
| US20030224411A1 (en) | 2003-03-13 | 2003-12-04 | Stanton Lawrence W. | Genes that are up- or down-regulated during differentiation of human embryonic stem cells |
| US7084246B2 (en) | 2003-04-17 | 2006-08-01 | Molecular Logix, Inc. | Epidermal growth factor agonists |
| US7985585B2 (en) | 2004-07-09 | 2011-07-26 | Viacyte, Inc. | Preprimitive streak and mesendoderm cells |
| US7541185B2 (en) | 2003-12-23 | 2009-06-02 | Cythera, Inc. | Methods for identifying factors for differentiating definitive endoderm |
| EP2722387B1 (en) | 2003-12-23 | 2019-12-11 | Viacyte, Inc. | Definitive endoderm |
| US8647873B2 (en) | 2004-04-27 | 2014-02-11 | Viacyte, Inc. | PDX1 expressing endoderm |
| US8586357B2 (en) | 2003-12-23 | 2013-11-19 | Viacyte, Inc. | Markers of definitive endoderm |
| US7625753B2 (en) | 2003-12-23 | 2009-12-01 | Cythera, Inc. | Expansion of definitive endoderm cells |
| US20050266554A1 (en) | 2004-04-27 | 2005-12-01 | D Amour Kevin A | PDX1 expressing endoderm |
| US20090155218A1 (en) | 2004-03-10 | 2009-06-18 | Alberto Hayek | Compositions and methods for growth of embryonic stem cells |
| BRPI0509282A (pt) | 2004-03-30 | 2007-09-18 | Univ California | compostos contendo hidrazida inibidores de cftr e seus usos |
| JP2005278501A (ja) * | 2004-03-30 | 2005-10-13 | Asahi Kasei Corp | 膵幹様細胞の分化誘導方法 |
| KR20070029681A (ko) | 2004-04-01 | 2007-03-14 | 위스콘신 얼럼나이 리서어치 화운데이션 | 줄기 세포의 내배엽 및 이자 혈통으로의 분화 |
| EP2377922B1 (en) | 2004-04-27 | 2020-04-08 | Viacyte, Inc. | PDX1 expressing endoderm |
| AU2005271723B2 (en) | 2004-07-13 | 2010-12-16 | Asterias Biotherapeutics, Inc. | Medium for growing human embryonic stem cells |
| US8187878B2 (en) | 2004-08-13 | 2012-05-29 | University Of Georgia Research Foundation, Inc. | Methods for increasing definitive endoderm differentiation of pluripotent human embryonic stem cells with PI-3 kinase inhibitors |
| US7517870B2 (en) | 2004-12-03 | 2009-04-14 | Fondazione Telethon | Use of compounds that interfere with the hedgehog signaling pathway for the manufacture of a medicament for preventing, inhibiting, and/or reversing ocular diseases related with ocular neovascularization |
| EP1676574A3 (en) | 2004-12-30 | 2006-07-26 | Johnson & Johnson Vision Care, Inc. | Methods for promoting survival of transplanted tissues and cells |
| AU2006210955A1 (en) | 2005-01-31 | 2006-08-10 | Es Cell International Pte Ltd. | Directed differentiation of embryonic stem cells and uses thereof |
| DK1864132T3 (da) | 2005-03-31 | 2012-07-16 | Stemnion Inc | Fra amnion stammende cellesammensætninger, fremgangsmåder til fremstilling deraf og anvendelser deraf |
| US9074181B2 (en) | 2005-06-22 | 2015-07-07 | Asterias Biotherapeutics, Inc. | Suspension culture of human embryonic stem cells |
| KR20130099253A (ko) | 2005-06-22 | 2013-09-05 | 제론 코포레이션 | 영장류 다능성 줄기 세포의 심근세포 계통 세포로의 분화 |
| EP1906972B1 (en) | 2005-07-19 | 2013-09-11 | The University of Tennessee Research Foundation | LPA2 receptor agonist for treating diarrhea |
| ES2687233T3 (es) | 2005-10-27 | 2018-10-24 | Viacyte, Inc. | Endodermo de intestino proximal dorsal y ventral que expresa PDX-1 |
| CN101330914A (zh) | 2005-12-16 | 2008-12-24 | 爱尔康公司 | 使用alk5调节剂控制眼内压 |
| WO2007075807A2 (en) | 2005-12-20 | 2007-07-05 | Es Cell International Pte Ltd. | Methods for the directed differentiation of embryonic stem cell |
| AU2007207434B2 (en) | 2006-01-20 | 2012-04-05 | Reneuron, Inc. | Method of improving cell proliferation of pancreatic progenitor cells in a pancreatic cell culture |
| EP1992360A4 (en) | 2006-02-01 | 2010-02-17 | Univ Tokyo | COMMON USE OF A TGF BETA SIGNAL HEMMER AND AN ANTITUMORAL AGENT |
| EP1989297B1 (en) | 2006-02-13 | 2015-03-25 | The Board of Trustees of The Leland Stanford Junior University | Blockade of gamma-secretase activity to promote myelination by oligodendrocytes |
| EP2420565B1 (en) | 2006-02-23 | 2017-08-30 | ViaCyte, Inc. | Compositions and methods useful for culturing differentiable cells |
| US7695965B2 (en) | 2006-03-02 | 2010-04-13 | Cythera, Inc. | Methods of producing pancreatic hormones |
| NZ571427A (en) | 2006-03-02 | 2012-07-27 | Viacyte Inc | Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production |
| WO2007109673A2 (en) | 2006-03-20 | 2007-09-27 | Stanford University | Mutant epidermal growth factor polypeptides, nucleic acids, and uses therefor |
| ES2725601T3 (es) | 2006-04-28 | 2019-09-25 | Lifescan Inc | Diferenciación de células madre embriónicas humanas |
| WO2007139929A2 (en) | 2006-05-25 | 2007-12-06 | The Burnham Institute For Medical Research | Methods for culture and production of single cell populations of human embryonic stem cells |
| US20090298169A1 (en) * | 2006-06-02 | 2009-12-03 | The University Of Georgia Research Foundation | Pancreatic and Liver Endoderm Cells and Tissue by Differentiation of Definitive Endoderm Cells Obtained from Human Embryonic Stems |
| WO2007149182A2 (en) | 2006-06-19 | 2007-12-27 | Geron Corporation | Differentiation and enrichment of islet-like cells from human pluripotent stem cells |
| WO2008013664A2 (en) | 2006-07-26 | 2008-01-31 | Cythera, Inc. | Methods of producing pancreatic hormones |
| CA2662209C (en) | 2006-08-29 | 2015-02-17 | The University Of Akron | Implantable devices for producing insulin |
| WO2008083331A2 (en) * | 2006-12-29 | 2008-07-10 | The Regents Of The University Of Colorado | Diagnostic and therapeutic target for autoimmune diseases and uses thereof |
| JP5636192B2 (ja) * | 2007-02-21 | 2014-12-03 | エス・ア・エール・エル アンドセルＳａｒｌ Ｅｎｄｏｃｅｌｌｓ | 糖尿病の診断のためのヒト膵臓β細胞株 |
| EP2142498A2 (en) | 2007-04-02 | 2010-01-13 | Institute for Oneworld Health | Cftr inhibitor compounds and uses thereof |
| WO2009012428A2 (en) | 2007-07-18 | 2009-01-22 | Lifescan, Inc. | Differentiation of human embryonic stem cells |
| RU2473685C2 (ru) | 2007-07-31 | 2013-01-27 | Лайфскен, Инк. | Дифференцировка человеческих эмбриональных стволовых клеток |
| JP5374370B2 (ja) | 2007-08-09 | 2013-12-25 | 株式会社ヤクルト本社 | 新規γセクレターゼ阻害剤 |
| US7695963B2 (en) | 2007-09-24 | 2010-04-13 | Cythera, Inc. | Methods for increasing definitive endoderm production |
| US8623650B2 (en) | 2007-10-19 | 2014-01-07 | Viacyte, Inc. | Methods and compositions for feeder-free pluripotent stem cell media containing human serum |
| CN107574142B (zh) | 2007-11-27 | 2021-07-06 | 生命扫描有限公司 | 人胚胎干细胞的分化 |
| SG154367A1 (en) * | 2008-01-31 | 2009-08-28 | Es Cell Int Pte Ltd | Method of differentiating stem cells |
| EP2265603B1 (en) | 2008-03-13 | 2014-05-07 | The General Hospital Corporation | Inhibitors of the bmp signaling pathway |
| US8338170B2 (en) | 2008-04-21 | 2012-12-25 | Viacyte, Inc. | Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells |
| DK2283117T3 (da) | 2008-04-21 | 2014-01-20 | Viacyte Inc | Fremgangsmåde til oprensning af pancreatiske endodermceller afledt fra humane embryoniske stamceller |
| US8728812B2 (en) | 2008-04-22 | 2014-05-20 | President And Fellows Of Harvard College | Compositions and methods for promoting the generation of PDX1+ pancreatic cells |
| US8623648B2 (en) | 2008-04-24 | 2014-01-07 | Janssen Biotech, Inc. | Treatment of pluripotent cells |
| US20090298178A1 (en) * | 2008-06-03 | 2009-12-03 | D Amour Kevin Allen | Growth factors for production of definitive endoderm |
| CA2729121C (en) | 2008-06-30 | 2019-04-09 | Centocor Ortho Biotech Inc. | Differentiation of pluripotent stem cells |
| US9683215B2 (en) * | 2008-08-22 | 2017-06-20 | President And Fellows Of Harvard College | Methods of reprogramming cells |
| WO2010033906A2 (en) | 2008-09-19 | 2010-03-25 | President And Fellows Of Harvard College | Efficient induction of pluripotent stem cells using small molecule compounds |
| JP2012507289A (ja) * | 2008-10-31 | 2012-03-29 | ヤンセン バイオテツク，インコーポレーテツド | ヒト胚性幹細胞の膵内分泌系への分化 |
| EP2346988B1 (en) * | 2008-10-31 | 2017-05-31 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells to the pancreatic endocrine lineage |
| US8008075B2 (en) | 2008-11-04 | 2011-08-30 | Viacyte, Inc. | Stem cell aggregate suspension compositions and methods of differentiation thereof |
| EP2356227B1 (en) | 2008-11-14 | 2018-03-28 | Viacyte, Inc. | Encapsulation of pancreatic cells derived from human pluripotent stem cells |
| CA2744227C (en) | 2008-11-20 | 2018-10-02 | Centocor Ortho Biotech Inc. | Methods and compositions for cell attachment and cultivation on planar substrates |
| GB201111244D0 (en) * | 2011-06-30 | 2011-08-17 | Konink Nl Akademie Van Wetenschappen Knaw | Culture media for stem cells |
| US8507274B2 (en) | 2009-02-06 | 2013-08-13 | President And Fellows Of Harvard College | Compositions and methods for promoting the generation of definitive endoderm |
| US20100267731A1 (en) | 2009-04-17 | 2010-10-21 | Summa Health Systems, LLC | Use of transforming growth factor-b receptor inhibitors to suppress ocular scarring |
| US9109245B2 (en) | 2009-04-22 | 2015-08-18 | Viacyte, Inc. | Cell compositions derived from dedifferentiated reprogrammed cells |
| ES2849181T3 (es) * | 2009-04-22 | 2021-08-16 | Viacyte Inc | Composiciones celulares derivadas de células reprogramadas desdiferenciadas |
| WO2010129294A2 (en) | 2009-04-27 | 2010-11-11 | Schulz Thomas C | Small molecules supporting pluripotent cell growth and methods thereof |
| WO2010135639A2 (en) * | 2009-05-21 | 2010-11-25 | Joslin Diabetes Center, Inc. | Compositions and methods for promoting beta cell maturity |
| EP2456858B1 (en) * | 2009-07-20 | 2018-08-29 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells |
| RU2540016C2 (ru) | 2009-07-20 | 2015-01-27 | Янссен Байотек, Инк. | Дифференцировка эмбриональных стволовых клеток человека |
| PH12012500818A1 (en) * | 2009-10-29 | 2019-11-29 | Janssen Biotech Inc | Pluripotent stem cells |
| DK2516625T3 (da) | 2009-12-23 | 2024-09-09 | Janssen Biotech Inc | Differentiering af humane embryonale stamceller |
| EP2505639B1 (en) * | 2009-12-29 | 2018-09-19 | Takeda Pharmaceutical Company Limited | Method for manufacturing pancreatic-hormone-producing cells |
| AU2011223900A1 (en) * | 2010-03-01 | 2012-09-13 | Janssen Biotech, Inc. | Methods for purifying cells derived from pluripotent stem cells |
| CA2800498C (en) | 2010-03-31 | 2021-11-16 | The Scripps Research Institute | Reprogramming cells |
| WO2011128897A1 (en) | 2010-04-12 | 2011-10-20 | Technion Research & Development Foundation Ltd. | Populations of pancreatic progenitor cells and methods of isolating and using same |
| JP2013524836A (ja) | 2010-04-25 | 2013-06-20 | マウント・シナイ・スクール・オブ・メディスン | 多能性細胞からの前部前腸内胚葉の生成 |
| AU2011250912A1 (en) * | 2010-05-12 | 2012-11-22 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells |
| AU2011290123B2 (en) * | 2010-08-09 | 2016-11-10 | Takeda Pharmaceutical Company Limited | Method of producing pancreatic hormone-producing cells |
| CN103052393B (zh) * | 2010-08-12 | 2017-11-14 | 詹森生物科技公司 | 用胰腺内分泌前体细胞治疗糖尿病 |
| GB201014169D0 (en) | 2010-08-25 | 2010-10-06 | Cambridge Entpr Ltd | In vitro hepatic differentiation |
| WO2012030540A2 (en) | 2010-08-31 | 2012-03-08 | Janssen Biotech, Inc. | Differentiation of pluripotent stem cells |
| CN103221536B (zh) | 2010-08-31 | 2016-08-31 | 詹森生物科技公司 | 人胚胎干细胞的分化 |
| KR101836850B1 (ko) | 2010-08-31 | 2018-03-09 | 얀센 바이오테크 인코포레이티드 | 인간 배아 줄기 세포의 분화 |
| WO2012044486A1 (en) | 2010-09-28 | 2012-04-05 | Baylor Research Institute | Induction of pancreatic stem cells by transient overexpression of reprogramming factors and pdxi selection |
| EP2508607A1 (en) | 2011-04-07 | 2012-10-10 | Helmholtz-Zentrum für Infektionsforschung GmbH | Medicament for liver regeneration and for treatment of liver failure |
| US20120270890A1 (en) * | 2011-04-22 | 2012-10-25 | Cheng-Ho Chung | Methods of Pancreatic Beta Cell Regeneration |
| WO2013000085A1 (en) | 2011-06-27 | 2013-01-03 | Alectos Therapeutics Inc. | Selective glycosidase inhibitors and uses thereof |
| MX364602B (es) | 2011-06-27 | 2019-05-02 | Alectos Therapeutics Inc | Inhibidores selectivos de glicosidasa y usos de los mismos. |
| US20130071931A1 (en) | 2011-08-02 | 2013-03-21 | National Cancer Center | Process for hepatic differentiation from induced hepatic stem cells, and induced hepatic progenitor cells differentiated thereby |
| US20140243374A1 (en) | 2011-10-04 | 2014-08-28 | The Brigham And Women's Hospital, Inc. | Novel Sulfonamides |
| ES2634457T3 (es) * | 2011-10-18 | 2017-09-27 | Univercell Biosolutions | Producción de una línea de células beta humanas a partir de un páncreas postnatal temprano |
| WO2013071282A1 (en) | 2011-11-13 | 2013-05-16 | Blanchette Rockefeller Neurosciences Institute | Pkc activators and combinations thereof |
| RU2705001C2 (ru) * | 2011-12-22 | 2019-11-01 | Янссен Байотек, Инк. | Дифференцировка эмбриональных стволовых клеток человека в одногормональные инсулинположительные клетки |
| US20140162359A1 (en) | 2012-05-07 | 2014-06-12 | Janssen Biotech, Inc. | Differentiation of Human Embryonic Stem Cells into Pancreatic Endoderm |
| CN104395323B (zh) | 2012-05-08 | 2017-08-01 | 默沙东公司 | 可透过性糖苷酶抑制剂及其用途 |
| WO2013166654A1 (en) | 2012-05-08 | 2013-11-14 | Merck Sharp & Dohme Corp. | Permeable glycosidase inhibitors and uses thereof |
| CN104334719B (zh) | 2012-06-08 | 2018-02-13 | 詹森生物科技公司 | 人胚胎干细胞向胰腺内分泌细胞的分化 |
| RU2015100900A (ru) | 2012-06-14 | 2016-08-10 | Янссен Байотек, Инк. | Обработка плюрипотентных клеток |
| EP2893000B1 (en) | 2012-09-03 | 2019-04-10 | Novo Nordisk A/S | Generation of pancreatic endoderm from pluripotent stem cells using small molecules |
| KR102084561B1 (ko) | 2012-12-31 | 2020-03-04 | 얀센 바이오테크 인코포레이티드 | 췌장 내분비 세포로의 분화를 위한 공기-액체 계면에서의 인간 배아 줄기세포의 배양 |
| MX2015008578A (es) * | 2012-12-31 | 2015-09-07 | Janssen Biotech Inc | Diferenciacion de celulas madre embrionarias humanas en celulas endocrinas pancreaticas mediante el uso de relugadores de hb9. |
| DK2938722T3 (da) | 2012-12-31 | 2022-02-14 | Janssen Biotech Inc | Suspension og klyngedannelse af humane pluripotente celler til differentiering til endokrine pankreasceller |
| WO2014130887A1 (en) | 2013-02-22 | 2014-08-28 | Cedars-Sinai Medical Center | Pancreatic insulin-producing beta-cell lines derived from human pluripotent stem cells |
| US20140287944A1 (en) | 2013-02-26 | 2014-09-25 | President And Fellows Of Harvard College | Markers for functionally mature beta-cells and methods of using the same |
| US8859286B2 (en) | 2013-03-14 | 2014-10-14 | Viacyte, Inc. | In vitro differentiation of pluripotent stem cells to pancreatic endoderm cells (PEC) and endocrine cells |
| PT2970205T (pt) | 2013-03-14 | 2019-08-26 | Tolero Pharmaceuticals Inc | Inibidores da jak2 e da alk2 e métodos para a sua utilização |
| US20140329704A1 (en) | 2013-03-28 | 2014-11-06 | President And Fellows Of Harvard College | Markers for mature beta-cells and methods of using the same |
| AU2014278178B2 (en) | 2013-06-11 | 2021-01-21 | President And Fellows Of Harvard College | SC-beta cells and compositions and methods for generating the same |
| DK3039122T3 (da) | 2013-08-30 | 2019-09-30 | Novo Nordisk As | Generering af endokrine progenitorceller fra humane pluripotente stamceller under anvendelse af små molekyler |
| SG11201609473XA (en) * | 2014-05-16 | 2016-12-29 | Janssen Biotech Inc | Use of small molecules to enhance mafa expression in pancreatic endocrine cells |
| ES2860423T3 (es) | 2014-05-28 | 2021-10-05 | Childrens Hospital Med Ct | Métodos y sistemas para convertir células precursoras en tejidos gástricos mediante diferenciación dirigida |
| SG11201700874SA (en) | 2014-08-04 | 2017-03-30 | Takeda Pharmaceuticals Co | Method for proliferation of pancreatic progenitor cells |
| WO2016100925A1 (en) | 2014-12-18 | 2016-06-23 | President And Fellows Of Harvard College | METHODS FOR GENERATING AUGMENTED STEM CELL-DERIVED β CELLS AND USES THEREOF |
| CN107614678B (zh) | 2014-12-18 | 2021-04-30 | 哈佛学院校长同事会 | 干细胞来源的β细胞的产生方法及其使用方法 |
| WO2016100921A1 (en) | 2014-12-18 | 2016-06-23 | President And Fellows Of Harvard College | METHODS FOR GENERATING STEM CELL-DERIVED β CELLS AND USES THEREOF |
| US10443042B2 (en) | 2014-12-18 | 2019-10-15 | President And Fellows Of Harvard College | Serum-free in vitro directed differentiation protocol for generating stem cell-derived beta cells and uses thereof |
| ES2985135T3 (es) | 2014-12-18 | 2024-11-04 | Harvard College | Procedimientos para generar células ß derivadas de células madre y usos de las mismas |
| US9974784B2 (en) | 2015-01-21 | 2018-05-22 | The Texas A&M University System | Inhibitors of activin-like receptor kinases |
| EP3420073B1 (en) | 2016-02-24 | 2023-11-08 | Novo Nordisk A/S | Generation of functional beta cells from human pluripotent stem cell-derived endocrine progenitors |
-
2014
- 2014-06-11 AU AU2014278178A patent/AU2014278178B2/en not_active Withdrawn - After Issue
- 2014-06-11 JP JP2016519628A patent/JP6677634B2/ja active Active
- 2014-06-11 CA CA3311831A patent/CA3311831A1/en active Pending
- 2014-06-11 KR KR1020217001204A patent/KR102341674B1/ko active Active
- 2014-06-11 KR KR1020217008409A patent/KR102361924B1/ko active Active
- 2014-06-11 RU RU2016100219A patent/RU2016100219A/ru not_active Application Discontinuation
- 2014-06-11 CN CN202510731517.6A patent/CN120796168A/zh active Pending
- 2014-06-11 DK DK14819763.5T patent/DK3008168T3/da active
- 2014-06-11 SG SG11201510176VA patent/SG11201510176VA/en unknown
- 2014-06-11 EP EP14810778.2A patent/EP3008170A4/en not_active Withdrawn
- 2014-06-11 SG SG10201710218RA patent/SG10201710218RA/en unknown
- 2014-06-11 US US14/898,015 patent/US20170029778A1/en not_active Abandoned
- 2014-06-11 KR KR1020227013185A patent/KR102523912B1/ko active Active
- 2014-06-11 CA CA2915088A patent/CA2915088A1/en active Pending
- 2014-06-11 CN CN201480045081.5A patent/CN106414718A/zh active Pending
- 2014-06-11 KR KR1020227024584A patent/KR102631225B1/ko active Active
- 2014-06-11 SG SG11201510177WA patent/SG11201510177WA/en unknown
- 2014-06-11 AU AU2014284677A patent/AU2014284677B2/en active Active
- 2014-06-11 GB GB1803318.3A patent/GB2557508B/en active Active
- 2014-06-11 EP EP14819763.5A patent/EP3008168B1/en active Active
- 2014-06-11 RU RU2016100433A patent/RU2692595C2/ru active
- 2014-06-11 KR KR1020227004200A patent/KR102423106B1/ko active Active
- 2014-06-11 KR KR1020247003026A patent/KR102773841B1/ko active Active
- 2014-06-11 EP EP24180310.5A patent/EP4461806A3/en active Pending
- 2014-06-11 DE DE112014002780.4T patent/DE112014002780B4/de active Active
- 2014-06-11 CN CN201480045183.7A patent/CN105579577A/zh active Pending
- 2014-06-11 EP EP19179173.0A patent/EP3569694A1/en active Pending
- 2014-06-11 CN CN202511434163.5A patent/CN121427797A/zh active Pending
- 2014-06-11 KR KR1020237031461A patent/KR102640729B1/ko active Active
- 2014-06-11 WO PCT/US2014/041988 patent/WO2015002724A2/en not_active Ceased
- 2014-06-11 WO PCT/US2014/041992 patent/WO2014201167A1/en not_active Ceased
- 2014-06-11 GB GB1622354.7A patent/GB2549822B/en active Active
- 2014-06-11 CN CN202011023525.9A patent/CN112226402A/zh active Pending
- 2014-06-11 KR KR1020217041325A patent/KR102390167B1/ko active Active
- 2014-06-11 JP JP2016519627A patent/JP6514689B2/ja active Active
- 2014-06-11 BR BR112015030972A patent/BR112015030972A8/pt not_active Application Discontinuation
- 2014-06-11 MX MX2015017103A patent/MX2015017103A/es unknown
- 2014-06-11 CA CA2915091A patent/CA2915091A1/en active Pending
- 2014-06-11 BR BR112015030946A patent/BR112015030946A8/pt not_active Application Discontinuation
- 2014-06-11 KR KR1020237012999A patent/KR102580225B1/ko active Active
- 2014-06-11 CN CN201910284587.6A patent/CN110551678B/zh active Active
- 2014-06-11 GB GB1521857.1A patent/GB2531952C/en active Active
- 2014-06-11 KR KR1020167000699A patent/KR102205234B1/ko active Active
- 2014-06-11 KR KR1020167000634A patent/KR102201638B1/ko active Active
- 2014-06-11 DE DE202014011287.8U patent/DE202014011287U1/de not_active Expired - Lifetime
- 2014-06-11 KR KR1020207036431A patent/KR102232650B1/ko active Active
-
2015
- 2015-04-10 US US14/684,101 patent/US10030229B2/en active Active
- 2015-04-10 US US14/684,129 patent/US20150240212A1/en not_active Abandoned
- 2015-12-11 PH PH12015502767A patent/PH12015502767A1/en unknown
- 2015-12-11 MX MX2019003616A patent/MX2019003616A/es unknown
-
2018
- 2018-07-23 US US16/042,917 patent/US10655106B2/en active Active
- 2018-07-23 US US16/042,933 patent/US20190017031A1/en not_active Abandoned
- 2018-12-17 HK HK18116147.8A patent/HK1257187B/zh unknown
-
2019
- 2019-02-11 US US16/273,076 patent/US20190169575A1/en not_active Abandoned
- 2019-04-12 JP JP2019076519A patent/JP6893527B2/ja active Active
-
2020
- 2020-03-13 JP JP2020044320A patent/JP7354026B2/ja active Active
- 2020-05-13 AU AU2020203127A patent/AU2020203127C1/en active Active
- 2020-07-21 US US16/934,412 patent/US11162078B2/en active Active
- 2020-07-21 US US16/934,503 patent/US11104883B2/en active Active
- 2020-07-21 US US16/934,333 patent/US11078463B2/en active Active
- 2020-12-14 AU AU2020289721A patent/AU2020289721B2/en active Active
-
2021
- 2021-06-01 JP JP2021091996A patent/JP2021121223A/ja active Pending
- 2021-10-29 US US17/514,609 patent/US20220162562A1/en not_active Abandoned
-
2022
- 2022-02-11 US US17/670,124 patent/US12054745B2/en active Active
- 2022-11-01 US US17/978,936 patent/US11827905B2/en active Active
-
2023
- 2023-04-21 JP JP2023070217A patent/JP7766641B2/ja active Active
- 2023-08-07 US US18/231,208 patent/US20240101963A1/en active Pending
- 2023-09-12 AU AU2023229504A patent/AU2023229504B2/en active Active
- 2023-09-25 AU AU2023237028A patent/AU2023237028B2/en active Active
- 2023-12-22 US US18/395,362 patent/US12049646B2/en active Active
-
2024
- 2024-02-08 JP JP2024017609A patent/JP2024054254A/ja active Pending
- 2024-06-13 US US18/742,930 patent/US20250019661A1/en active Pending
- 2024-09-30 US US18/902,580 patent/US20250043247A1/en active Pending
-
2025
- 2025-01-23 JP JP2025009884A patent/JP2025063288A/ja active Pending
-
2026
- 2026-01-29 JP JP2026012730A patent/JP2026082908A/ja active Pending
- 2026-04-02 AU AU2026202516A patent/AU2026202516A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL287319A (en) | Genetically-modified cells comprising a modified human t cell receptor alpha constant region gene | |
| HUE059737T2 (hu) | Glükagon, GLP-1 és GIP receptor aktiváló tripla aktivátor | |
| EP3615661C0 (en) | BI- OR MULTI-DIFFERENTIATED ORGANOID | |
| MX2018005132A (es) | Agonistas del receptor de glucagon. | |
| MX346957B (es) | Agonistas de receptor de glp-1/glucagón de acción prolongada. | |
| DK3207130T3 (da) | Sammensætninger af Adenosin Deaminase-2 (ADA2), varianter deraf og fremgangsmåder til anvendelse af samme | |
| WO2014106846A3 (en) | Methods and compositions for treating nafld, hepatic steatosis, and sequelae thereof | |
| EP3160476A4 (en) | Substituted nucleosides, nucleotides and analogs thereof | |
| EP3253773A4 (en) | Substituted nucleosides, nucleotides and analogs thereof | |
| DK3155101T3 (da) | Sammensætninger og fremgangsmåder til ekspression af CRISPR-leder-RNA´er under anvendelse af H1-promotoren | |
| JP2017502668A5 (enExample) | ||
| EP4265250A3 (en) | Solid forms of an ask1 inhibitor | |
| EP3665297A4 (en) | DIGITAL AMPLIFICATION WITH LIMITED NUCLEOTIDIC COMPOSITION PRIMERS | |
| JP2016528887A5 (enExample) | ||
| DK3242957T3 (da) | Bakterieholdige sammensætninger og fremgangsmåder til anvendelse af samme til behandling og/eller forebyggelse af gastrointestinale, metaboliske og/eller andre sygdomme | |
| WO2016210416A3 (en) | Genetically modified ips cells that carry a marker to report expression of neurogenin3, tph2, foxo1 and/or insulin genes | |
| EP3202409A4 (en) | Composition, cell construct, islet transplant kit, islet cell transplant therapeutic agent and blood sugar reducing agent, composition including islets, kit including islets, and islet transplant therapeutic agent and blood sugar reducing agent | |
| EP3268016A4 (en) | Pancreatic endocrine progenitor cell therapies for the treatment of obesity and type 2 diabetes (t2d) | |
| EP3704059A4 (en) | Digital nucleic acid amplification using encoded particles | |
| WO2015155360A8 (en) | TRANSGENIC PORK ISLANDS AND THEIR USES FOR THE TREATMENT OF DIABETES | |
| WO2016069518A3 (en) | Genetically stable replication competent sendai virus vector(s) containing and expressing optimized hiv genes | |
| EP3297991A4 (en) | Novel amidoheteroaryl aroyl hydrazide ethynes | |
| EP3678682A4 (en) | METHOD, COMPOSITIONS AND CELLS FOR MANUFACTURING SURFACTANT PROTEIN D (SP-D) | |
| EP3214171A4 (en) | Placenta-derived cells excreting c3 or c1r complement and composition containing same | |
| EP3194602A4 (en) | Compounds and methods for enhancing viral gene transfer to human hematopoietic cells |